Abintus Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Out of Business

Abintus Bio General Information

Description

Developer of a gene therapy designed to provide products that modulate immune cells from within their native environment for desired patient outcomes. The company focuses on the discovery and development of a portfolio of first-in-class product candidates to directly reprogram immune cells using proprietary vectors and related technologies, enabling healthcare firms to empower patients' immune cells to fight their disease from within.

Contact Information

Website
www.abintusbio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 10355 Science Center Drive
  • Suite 250
  • San Diego, CA 92121-1158
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 10355 Science Center Drive
  • Suite 250
  • San Diego, CA 92121-1158
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abintus Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 15-Jul-2025 Completed Out of Business
3. Early Stage VC 15-Aug-2022 Completed Pre-Clinical Trials
2. Early Stage VC 22-Apr-2021 Completed Pre-Clinical Trials
1. Early Stage VC 01-Jan-2020 Completed Pre-Clinical Trials
To view Abintus Bio’s complete valuation and funding history, request access »

Abintus Bio Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

Abintus Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024243460-A1 Vectors and methods for in vivo transduction Inactive 23-May-2023
US-20260139275-A1 Stem cell based delivery of tumor-specific retroviral vectors Pending 17-Oct-2022
AU-2021273253-A1 Vectors and methods for in vivo transduction Inactive 11-May-2020
CA-3176697-A1 Vectors and methods for in vivo transduction Pending 11-May-2020
EP-4149495-A1 Vectors and methods for in vivo transduction Inactive 11-May-2020 C07K16/2815
To view Abintus Bio’s complete patent history, request access »

Abintus Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Abintus Bio FAQs

  • When was Abintus Bio founded?

    Abintus Bio was founded in 2020.

  • Where is Abintus Bio headquartered?

    Abintus Bio is headquartered in San Diego, CA.

  • What is the size of Abintus Bio?

    Abintus Bio has 13 total employees.

  • What industry is Abintus Bio in?

    Abintus Bio’s primary industry is Drug Discovery.

  • Is Abintus Bio a private or public company?

    Abintus Bio is a Private company.

  • What is Abintus Bio’s current revenue?

    The current revenue for Abintus Bio is .

  • How much funding has Abintus Bio raised over time?

    Abintus Bio has raised $13.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process